Overview
McDermott is a proud sponsor of the American Conference Institute’s (ACI) 21st Annual Paragraph IV Disputes conference. Partners Doug Carsten and Mike Sitzman are speaking at the event, which addresses the hot topics in the pharmaceutical patent industry and places them within the context of pre-suit considerations, case filings, final adjudication, and every step in between.
Doug is speaking on the breakout session, “PIV Practitioner Perspectives on Confidentiality and the Scope of Privilege.” The session explores the critical aspects of protecting communications concerning infringement and invalidity positions. He and his co-panelists will discuss safeguarding these communications to ensure they remain confidential, maintaining product confidentiality to avoid the risk of follow-on patents, and examining how patent cases can trigger the crime-fraud exemption to attorney-client privilege and its implications for legal strategy.
Mike’s speaking on the panel, “Charting the Evolving Boundaries of the Safe Harbor 35 USC § 271 in View of Recent Case Law.” The panel provides insights into what activities are and are not shielded by the safe harbor, explores the differing perspectives of brand and generic companies on the scope of conduct covered by the safe harbor, examines where safe harbor defenses are holding up and where they are being defeated, and more.
